| 000 | 01415 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250516201838.0 | ||
| 264 | 0 | _c20150128 | |
| 008 | 201501s 0 0 eng d | ||
| 022 | _a1471-2334 | ||
| 024 | 7 |
_a10.1186/1471-2334-14-133 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJain, Varsha K | |
| 245 | 0 | 0 |
_aA historically-controlled Phase III study in adults to characterize the acceptability of a process change for manufacturing inactivated quadrivalent influenza vaccine. _h[electronic resource] |
| 260 |
_bBMC infectious diseases _cMar 2014 |
||
| 300 |
_a133 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase III; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aDrug Compounding |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHistorically Controlled Study |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInfluenza Vaccines _xadministration & dosage |
| 650 | 0 | 4 |
_aInfluenza, Human _ximmunology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aThimerosal _xadministration & dosage |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aChandrasekaran, Vijayalakshmi | |
| 700 | 1 | _aWang, Long | |
| 700 | 1 | _aLi, Ping | |
| 700 | 1 | _aLiu, Aixue | |
| 700 | 1 | _aInnis, Bruce L | |
| 773 | 0 |
_tBMC infectious diseases _gvol. 14 _gp. 133 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1186/1471-2334-14-133 _zAvailable from publisher's website |
| 999 |
_c23620373 _d23620373 |
||